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Abstract
Intruoduction High mobility group box 1 (HMGB1), a
ubiquitous nuclear protein, induces several inflammatory
diseases and functions as a fatal factor when released
extracellularly. The effect of HMGB1 on vascular reac-
tivity during sepsis remains to be clarified.
Methods A rat model of abdominal sepsis was produced
by cecal ligation and puncture (CLP) under sevoflurane
anesthesia (n = 28). Anti-HMGB1 antibody at a dose of 4
or 0.4 mg/kg, or normal saline was injected twice intra-
venously, i.e., immediately after the CLP surgery and 4 h
thereafter. Rats in the sham group underwent laparotomy,
and the cecum was manipulated but not ligated or punc-
tured. The descending thoracic aorta was excised 12 h after
the CLP surgery and cut into rings of approximately 3 mm
in length. Changes in the expression of HMGB1 and vas-
cular reactivity were examined in the rings shortly after
harvest and 4 h thereafter.
Results HMGB1 was identified immunohistochemically
and by Western blotting in the nuclei of vascular endo-
thelial and smooth muscle cells in all groups shortly after
excision of the aorta, but its expression was augmented
only in the CLP groups 4 h thereafter. Degenerated smooth
muscle cells were also observed after CLP. Anti-HMGB1
antibody dose-dependently inhibited the augmentation of
HMGB1 expression and the morphological changes
induced by CLP. The expression of HMGB1 partly corre-
lated with suppression of vascular reactivity.
Conclusion The present results strongly suggest that
HMGB1 plays an important role in vascular malfunction
from an early phase of sepsis.
Keywords HMGB1  Vascular smooth muscle 
Endothelium  Sepsis  Rat aorta
Introduction
High mobility group box 1 (HMGB1) is a ubiquitous
nuclear protein present in many eukaryotic cells that sta-
bilizes nucleosomes and enables gene transcription by
binding to DNA [1]. When released to the extracellular
space, however, HMGB1 induces several inflammatory
diseases and functions as a late mediator, or as a fatal factor
[2, 3]. During the early phase of sepsis, many proinflam-
matory cytokines, including tumor necrosis factor (TNF)-a
and interleukin (IL)-1, are released by macrophages in
response to endotoxin. HMGB1 is actively released by
monocytes/macrophages more than 8 h after stimulation
with endotoxin, TNF-a, or IL-1 [2, 4]. HMGB1 ligates
three receptors expressed on the surface of endothelial and
smooth muscle cells: the receptor for advanced glycation
end products (RAGE), the toll-like receptor (TLR) 2, and
TLR4 [5–7]. Endothelial cells stimulated with HMGB1
show increased expression of intercellular and vascular
adhesion molecules and RAGE receptor, as well as
increased secretion of TNF-a and chemokines, resulting in
endothelial cell activation and injury [8]. HMGB1 and
RAGE are known to regulate transendothelial migration of
monocytes/macrophages [9], and cytoskeleton reorganiza-
tion in smooth muscle cells [10].
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It has been reported in the murine myocardium that
cardiac dysfunction and HMGB1 expression are induced as
early as 12 h after cecal ligation and puncture (CLP) sur-
gery [11, 12]. Furthermore, glucan phosphate, a carbohy-
drate ligand that modulates innate immunity and
proinflammatory signaling in sepsis, has been shown to
improve cardiac function and HMGB1 translocation from
the nucleus to the cytoplasm in the myocardium [11, 12].
These reports indicate that HMGB1 is not merely a late
mediator but it is expressed in tissues from an earlier phase
of sepsis and affects organ function. Cardiac dysfunction
and vascular hyporeactivity are major consequences of
severe sepsis and septic shock. It is well known clinically
and experimentally that a-adrenergic vasoconstriction
becomes attenuated during sepsis [13, 14]. Inducible nitric
oxide synthase is expressed in septic vessels leading to an
overproduction of nitric oxide [15]. Prostaglandins are also
overproduced during sepsis [16], resulting in a negative
inotropic effect on the heart [17] and hyporeactivity of
blood vessels [18]. However, the role of HMGB1 regarding
vascular reactivity has not been clarified, especially during
the early phase of sepsis.
In this study, we used a rat model of CLP-induced sepsis
to examine how HMGB1 influences vascular reactivity 12
and 16 h after peritonitis. We aimed at clarifying the
relationship between vascular hyporeactivity and expres-
sion of HMGB1, both in the endothelium and vascular
smooth muscle.
Materials and methods
Animals and protocol for induction of intraabdominal
sepsis
This study was approved by the Animal Care and Use
Committee of Kanazawa Medical University. All experi-
mental procedures and handling of the animals were in
accordance with the animal experiment guidelines of the
National Institutes of Health Guide for the Care and Use of
Laboratory Animals.
Male Sprague–Dawley rats weighing 200 and 250 g
(n = 28) were used in the experiments. Intraabdominal
sepsis was induced using the CLP technique (CLP group).
Briefly, laparotomy through a midline abdominal incision
was performed under sevoflurane anesthesia. An infrared
heating lamp was used to prevent hypothermia throughout
the surgery. The cecum was ligated with 3-0 ligature just
below the ileocecal valve, so that intestinal continuity was
maintained. The cecum was then punctured in two loca-
tions using an 18-gauge needle on the antimesenteric sur-
face of the cecum, and was gently compressed until feces
were slightly extruded. The bowel was returned to the
abdomen and the incision was closed with a layer of pro-
line sutures for the muscles and 3-0 silk for the skin. Rats
in the sham operation group underwent laparotomy under
sevoflurane anesthesia, and the cecum was manipulated but
not ligated or punctured (sham group). All the animals
were administered 60 ml/kg normal saline (NS) subcuta-
neously in their back after closure of the abdomen. Then,
inhalation of sevoflurane was withheld, and the rats were
observed in a recovery cage, deprived of food and water.
Experimental protocol
In the CLP group rats, chicken anti-rabbit HMGB1 poly-
clonal antibody (Shino-test, Tokyo, Japan) at 4 mg/kg
(CLP ? 4 mgAb group; n = 7) or 0.4 mg/kg
(CLP ? 0.4 mgAb group; n = 7) in 1 ml NS or the same
volume of NS (CLP ? NS group; n = 7) was injected
twice through the tail vein under light sevoflurane anes-
thesia immediately after the surgery and 4 h thereafter
[19]. The sham group rats (n = 7) received only NS in a
similar time course. The descending thoracic aorta was
excised under deep sevoflurane anesthesia 12 h after the
surgery, and placed in a cold, oxygenated (95 % O2:5 %
CO2) physiological salt solution (PSS), with the following
composition (in mM): NaCl, 118.3; KCl, 4.7; CaCl2, 2.5;
MgSO4, 1.2; KH2PO4, 1.2; NaHCO3, 25.0; Ca-ethylene-
diaminetetraacetic acid (EDTA), 0.026; and glucose, 11.1.
The aorta was gently cleaned of surrounding fat and con-
nective tissue and cut into five rings approximately 3 mm
in length. Then, two rings were incubated in an organ
chamber filled with warm (37 C, pH 7.4) oxygenated PSS
for 4 h. The expression of HMGB1 in the aortic rings was
analyzed by immunohistochemistry and Western blotting
both shortly after preparing the aortic rings and after 4 h of
incubation (two rings from each rat). For the immunohis-
tochemical evaluation, the rings were fixed with 10 %
buffered formaldehyde for 12 h at room temperature,
dehydrated with a series of ethanol, and embedded in
paraffin. To simultaneously localize the HMGB1 protein
and detect macrophages in the rings, these were stained
using anti-macrophage and anti-HMGB1 antibodies and
examined under a fluorescence microscope. For the Wes-
tern blotting analysis, two aortic rings were frozen in liquid
nitrogen and stored at -80 C until analysis.
Vascular reactivity was analyzed in the remaining ring.
This aortic ring was suspended between two stainless steel
wires in an organ chamber filled with 25 ml PSS (37 C,
pH 7.4) and gassed with a 95 % O2:5 % CO2 mixture. One
of the wires was anchored in the organ chamber, and the
other was connected to a strain gauge to measure isometric
force. The aortic ring was progressively stretched and
exposed to 40 mM KCl until the maximum contractile
response was obtained. We used this maximum response to
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KCl as a reference tension. Then, phenylephrine (PE), an
a1-adrenergic agonist, was administered cumulatively to
the organ chamber to obtain final concentrations ranging
from 10–9 M to 10-5 M. After washing the aortic ring with
PSS several times, the ring was contracted with PE to cause
approximately 60 % of the maximum PE-induced con-
traction (ED60). Then, acetylcholine (Ach), an endothe-
lium-dependent vasodilator, was added cumulatively to the
organ chamber to obtain final concentrations ranging from
10-9 M to 10-5 M. These procedures were repeated twice
with an interval of approximately 4 h.
Immunohistochemical procedures
The expression of HMGB1 was examined in aortic cross
sections. Briefly, after 3-lm paraffin-embedded sections
were deparaffinized in xylene, they were hydrated in a
descending ethanol series and tap water. The sections were
then incubated with 3 % H2O2 for 10 min to reduce endog-
enous peroxidase activity, and underwent antigen retrieval in
10 mM citrate buffer (pH 6.0) with 0.1 % Tween 20 for
15 min at 121 C. Then, the sections were reacted with
rabbit monoclonal anti-HMGB1 antibody (Epitomics, Bur-
lingame, CA, USA) at a concentration of 0.75 lg/ml for 2 h
at room temperature. The antibodies applied were visualized
using the avidin–biotin–peroxidase technique (DAKO
LSAB kit; DakoCytomation, Carpinteria, CA, USA) fol-
lowed by chromogen detection with diaminobenzidine
(DakoCytomation). The sections were counterstained with
Mayer’s hematoxylin. The renal medulla was used as the
positive control for HMGB1 because HMGB1 expression in
renal tissue has been confirmed [20]. As the negative control,
phosphate-buffered solution (PBS) was applied instead of
the first antibody. Three sections were randomly selected
from each animal to count the number of HMGB1-positive
cells more than 250 lm in width.
Double-labeled immunofluorescence staining
The sections were deparaffinized and underwent antigen
retrieval the same as for immunohistochemistry. After
blocking with 1 % bovine serum albumin (Wako, Osaka,
Japan) for 30 min at room temperature, the sections were
reacted with a mixture of rabbit monoclonal HMGB1
antibody (Epitomics) at a concentration of 10 lg/ml and
mouse monoclonal anti-rat macrophage antibody (BMA-
Biomedicals, Augst, Switzerland) at a concentration of
10 lg/ml for 2 h at room temperature. After washing with
PBS, the sections were incubated for 1 h at room temper-
ature with a mixture of Alexa Fluor 488-conjugated goat
anti-rabbit IgG antibody (Invitrogen, Grand Island, NY,
USA) diluted 1:200 and Alexa Fluor 594-conjugated goat
anti-mouse IgG antibody (Invitrogen) diluted 1:200 in
PBS. The sections were viewed with an LSM 710 Confocal
Microscope (Carl Zeiss Japan, Tokyo) and were photo-
graphed digitally using LSM software ZEN 2010 (Carl
Zeiss Japan).
Western blotting analysis
After the rings were subsequently thawed in room air,
homogenized in lysis buffer [50 mM Tris–HCl (pH 7.6),
10 % glycerol, 5 mM magnesium acetate, 0.2 mM EDTA,
1 mM phenylmethylsulfonyl fluoride, and 1 % sodium
dodecylsulfate], and centrifuged for 10 min at 15,000 g, at
4 C. The supernatant was collected, and the protein
(10 lg) was applied to and electrophoresed on a 10 %
polyacrylamide gel and transferred to a nitrocellulose
membrane (Atoh, Tokyo, Japan). The membrane was
reacted overnight at 4 C with rabbit monoclonal anti-
HMGB1 antibody (Epitomics) at a concentration of
1 lg/ml. After incubation with peroxidase-labeled goat
anti-rabbit IgG antibody (DakoCytomation) for 1 h at room
temperature and vigorous washing, the nitrocellulose
membrane was incubated with Immuno Star Kit (Wako)
and photographed digitally using Image Quant LAS 4000
(GE Healthcare Japan, Tokyo). All samples were stan-
dardized by immunoblot using anti-b-actin mouse mono-
clonal antibody (Sigma, St. Louis, MO, USA).
Measurement of vasoreactivity
To observe vascular response, we used the PowerLab organ
bath system (AD Instruments Japan, Nagoya), and vascular
tension was continuously monitored with the Chart soft-
ware v3.6.1 (AD Instruments Japan).
Statistical analysis
Results are presented as the mean ± standard deviation.
For continuous variables, the Student t test was used for
comparison between two groups and one-way analysis of
variance (ANOVA) for multiple comparisons with the post
hoc Fisher’s LSD test. For categorical variables, Mann–
Whitney U test was used for comparison between two
groups and Kruskal–Wallis test for multiple comparisons.
If a significant difference was obtained using the Kruskal–
Wallis test, Mann–Whitney U test with Bonferroni cor-
rection was used for post hoc analysis. A P value less than
0.05 was considered statistically significant.
Results
Figure 1a shows the immunohistochemical findings in the
aortic rings in the four groups. Although HMGB1 was
686 J Anesth (2013) 27:684–692
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expressed in the nuclei of the endothelium in all groups even
shortly after the preparation, the number of HMGB1-positive
endothelial cells in the CLP groups (23 ± 2 in the
CLP ? NS group, 11 ± 6 in the CLP ? 4 mgAb group, and
12 ± 7 in the CLP ? 0.4 mgAb group) was significantly
greater than that in the sham group (4 ± 3; Fig. 1b). The
number of HMGB1-positive endothelial cells did not change
significantly in aortic rings examined 4 h after the prepara-
tion in the sham (6 ± 3), CLP ? NS (24 ± 1), and
CLP ? 4 mgAb (12 ± 6) groups. In contrast, the number of
HMGB1-positive endothelial cells was significantly
increased at this time point in the CLP ? 0.4 mgAb group
(23 ± 1). As shown in Fig. 1c, HMGB1 was also expressed
in the nuclei of smooth muscle cells; 1 ± 1 in the sham
group, 4 ± 2 in the CLP ? NS group, 1 ± 1 in the
CLP ? 4 mgAb group, and 1 ± 1 in the CLP ? 0.4 mgAb
group. The number of HMGB1-positive smooth muscle cells
was significantly greater in the CLP ? NS group than that in
the sham group shortly after the preparation. The number of
HMGB1-positive smooth muscle cells was increased at the
4-h time point and reached a statistically significant level as
compared to that shortly after the preparation in the
CLP ? NS (44 ± 5) and CLP ? 0.4 mgAb (20 ± 5)
groups, whereas it did not change significantly in the sham
(2 ± 0) and CLP ? 4 mgAb (2 ± 1) groups.
In addition to HMGB1 expression, degenerated smooth
muscle cells with dark-stained cytoplasm could be
observed only in the CLP ? NS group. The number of
degenerated smooth muscle cells was increased after 4 h
incubation compared with that shortly after the preparation
(31 ± 21 and 113 ± 39 at shortly after preparation and 4 h
thereafter, respectively; P = 0.016). Furthermore, in the
sham group smooth muscle cells were all lined in a wavy
fashion shortly after the preparation and 4 h thereafter. In
contrast, in the CLP ? NS group smooth muscle cells were
all lined straight both shortly after the preparation and 4 h
thereafter (P = 0.0025 vs. the sham group). In the
CLP ? 4 mgAb group, smooth muscle cells were lined
wavily in all rings shortly after the preparation
(P = 0.0025 vs. the CLP ? NS group), whereas they were
lined straight in 2 of 7 rings 4 h thereafter. In the
CLP ? 0.4 mgAb group, although smooth muscle cells
were lined wavily in 6 of 7 rings shortly after the prepa-
ration (P = 0.014 vs. the CLP ? NS group), they were
lined straight 6 of 7 rings 4 h thereafter (P = 0.037 vs.
shortly after the preparation). These results indicate that
morphological changes develop as HMGB1 expression
increases in smooth muscle cells after CLP.
Figure 2 shows double-labeled immunofluorescence
staining using anti-HMGB1 and anti-macrophage antibodies.
In the sham group, HMGB1 protein expression (green) was
restricted to the endothelium shortly after the preparation and
4 h thereafter. No macrophages were observed in the vascular
slices in the sham group. To the contrary, HMGB1 protein was
expressed in the endothelium and macrophages were attached
to it in the CLP ? NS group shortly after the preparation. The
expression of HMGB1 protein was spread into the nuclei of
smooth muscle cells 4 h thereafter. In addition, macrophages
were identified in the smooth muscle layer in the CLP ? NS
group 4 h after the preparation. The changes in the expression
of HMGB1 protein and macrophage migration observed in the
CLP ? NS group were almost completely inhibited in the
CLP ? 4 mgAb group, whereas they were partly suppressed
in the CLP ? 0.4 mgAb group.
The results of Western blotting analysis of HMGB1 in
the aortic rings are shown in Fig. 3 as density relative to
that of b-actin. Expression of HMGB1 shortly after prep-
aration of the rings was significantly greater in the
CLP ? NS group than in the other three groups. Although
the expression of HMGB1 increased during incubation for
4 h as compared to that shortly after the preparation, only
in the CLP ? NS and CLP ? 0.4 mgAb groups it reached
levels of statistical significance.
PE-induced vascular contractions are depicted in
Fig. 4a, b. As compared to the sham group, PE-induced
contraction was significantly attenuated in the CLP groups
irrespective of the administration of anti-HMGB1 anti-
bodies in the first series (Fig. 4a). There were no significant
differences in contractile response among the CLP groups.
In the second series performed 4 h after the first one
(Fig. 4b), PE-induced contraction was comparable to the
first one in the sham group, as well as in the CLP groups
administered anti-HMGB1 antibodies (P = 0.81, 0.90, and
0.42 for the sham, CLP ? 4 mgAb, and CLP ? 0.4 mgAb
groups, respectively). In contrast, PE-induced contraction
was further attenuated in the second series compared to the
first one in the CLP ? NS group (P = 0.043). As a result,
a significant difference in the PE-induced contraction was
observed between the CLP ? 4 mgAb group and the
CLP ? NS group (P = 0.017).
Ach-induced vasodilation is shown in Fig. 4c, d. Ach-
induced vasodilation was inconsistent and showed
remarkable variation among the aortic rings in the CLP ?
0.4 mgAb group. We excluded this group from data anal-
ysis, and Ach-induced vasodilation was examined only in
the sham, CLP ? 4 mgAb, and CLP ? NS groups. Ach
dose-dependently relaxed the rings preconstricted with PE
in the three groups in both the first and second series. Ach at
the dose of 10-5 M caused maximum endothelium-induced
vasodilation of approximately 80–90 % of preconstriction
in the sham group. In the CLP groups, however, maximum
vasodilation was attenuated as compared to the sham group
(P \ 0.05). These results indicate that abdominal sepsis
inhibits not only PE-induced vasoconstriction but also
endothelium-induced vasodilation, both of which were
partly restored by anti-HMGB1 antibody.
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Fig. 1 a Immunohistochemical
imaging of a rat aortic section.
9100. Dark brown indicates
high mobility group box 1
(HMGB1) protein. b Number of
immunohistochemically defined
HMGB1-positive endothelial
cells. c Number of
immunohistochemically defined
HMGB1-positive smooth
muscle cells in the four groups.
White columns indicate the strip
shortly after preparation; black
columns indicate the strip after
4 h incubation. Each, n = 7













Fig. 2 Double-labeled immunofluorescence imaging of an aortic
section. 9400. Green indicates HMGB1 protein; red indicates
macrophages. In the sham group, HMGB1 protein expression (yellow
arrowheads) was restricted to the endothelium shortly after the
preparation and 4 h thereafter. No macrophage (white arrows) was
observed in the vascular slices. In contrast, HMGB1 protein was
expressed in the endothelium and macrophages were attached to it in
the NS group shortly after the preparation. The expression of HMGB1
protein extended to the nuclei of smooth muscle cells and macro-
phages were identified in the smooth muscle layer 4 h thereafter. The
changes in expression of HMGB1 protein and macrophage migration
observed in the NS group were almost completely inhibited in the
4 mgAb group, whereas they were partly suppressed in the 0.4 mgAb
















Fig. 3 Expression of HMGB1
analyzed by Western blotting in
the four groups. The expression
is presented as density relative
to that of b-actin. White
columns indicate the strip
shortly after preparation; black
columns indicate the strip after
4 h incubation. Each, n = 7,
each. See text for details
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Discussion
In the present study, we demonstrated that HMGB1 was
expressed in the endothelium of the descending thoracic
aorta 12 h after CLP surgery and that 4 h later it was also
expressed in smooth muscle cells. Moreover, we showed
that morphological changes became apparent when
HMGB1 expression was detected in smooth muscle cells,
and these changes were partly reversed by anti-HMGB1
antibody. Besides, both PE-induced vasoconstriction and
Ach-induced endothelium-dependent vasodilation were
attenuated in the thoracic aorta 12 h after CLP surgery, and
this hyporeactivity was even more marked at 4 h thereafter
(second series). In addition, anti-HMGB1 antibody
administered after CLP surgery partially but dose-depen-
dently reversed the progression of HMGB1 expression and
the attenuation of vascular responses. These results
strongly indicate that HMGB1 is a mediator responsible for
vascular inflammation and hyporeactivity in sepsis.
HMGB1 is induced in patients with inflammatory dis-
eases, and the serum concentration of HMGB1 is increased
during peripheral tissue insult [21–24]. Therefore, it is not
surprising that HMGB1 was expressed in the endothelium
even after the sham surgery. The most striking findings of
the present study were that the expression of HMGB1
increased and macrophages migrated to the smooth muscle
layer only in the CLP group of the ex vivo experiment,
when neither HMGB1 nor proinflammatory cytokines were
present in the medium around the rings. In addition, anti-
HMGB1 antibody administered in vivo partly but dose-
dependently neutralized the morphological and functional
changes observed in aortic rings from rats challenged by
CLP. These results indicate that the endothelium was
activated as early as 12 h after CLP surgery, resulting in
leukocyte adherence and loss of the barrier function. This
observation is consistent with the findings reported by Susa
et al. [19], who showed that serum HMGB1 levels peaked





Fig. 4 Left Phenylephrine-induced vascular contraction in the four
groups (a, b). Reference tension (100 %) was obtained with 40 mM
KCl before phenylephrine challenge. a Aortic ring shortly after
preparation. b Aortic ring 4 h thereafter. Right Acetylcholine-induced
vasodilation in the sham, CLP ? NS, and CLP ? 4 mgAb groups
(c, d). The CLP group administered CLP ? 0.4 mgAb was omitted
from the calculation because acetylcholine-induced vasodilation was
inconsistent from ring to ring. The ring was preconstricted with
phenylephrine to obtain approximately 60 % of the maximum
contraction (ED60). c Aortic ring shortly after preparation. d Aortic
ring 4 h thereafter. Data are expressed as the mean ± standard
deviation. Each, n = 7. *P \ 0.05 versus the sham group at the
respective time point, P \ 0.05 versus the ring shortly after the
preparation in the same group, P \ 0.05 versus the 4 mgAb group at
the same time point, §P \ 0.05 versus the NS group at the respective
time point
b
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[11, 12], who found that cardiac dysfunction and HMGB1
expression were induced 12 h after CLP surgery.
To our best knowledge, this is the first report showing
the expression and significance of HMGB1 in the rat aorta
during sepsis. Furthermore, HMGB1 expression seemed to
be limited to the nuclei of endothelial and smooth muscle
cells in this study. It has been shown that HMGB1 is
expressed in smooth muscle cells underlying atheroscle-
rotic lesions [25, 26]. However, in those studies, most
HMGB1 immunoreactivity was observed in the cytoplasm
as compared to that in the nucleus. Thus, our findings
together with those of Kalinina et al. [25] and Inoue et al.
[26] suggest that HMGB1 expression is augmented but
restricted to the nucleus of smooth muscle cells during the
early phase of inflammation, whereas in the chronic
inflammatory status, HMGB1 is also expressed in the
cytoplasm.
Several mechanisms have been advocated to induce
vascular hyporeactivity during sepsis [13–16, 18]. In the
present study, HMGB1 expression in aortic rings showed a
fair and negative correlation with both PE-induced con-
traction and Ach-induced endothelium-mediated vasodila-
tion. The present study did not clarify the exact
mechanisms by which expression of HMGB1 in the
nucleus produced vascular hyporeactivity during sepsis.
Although in previous studies the exact mechanisms were
not delineated either, the relationship between HMGB1
expression and organ injury was demonstrated in the lungs
[27, 28], heart [11, 12], and diaphragm [19]. Administra-
tion of anti-HMGB1 antibody was effective to alleviate
both sepsis-induced and non-sepsis-induced organ injury
[21, 24, 29]. Degryse et al. [10] have reported that HMGB1
not only stimulates migration of rat smooth muscle cells by
chemotaxis, but also induces rapid and transient changes of
the cell shape and actin cytoskeleton reorganization, lead-
ing thereby to an elongated polarized morphology. In this
study, morphological changes in smooth muscle cells
coincided with HMGB1 expression and vascular mal-
function, indicating that HMGB1 expression has a key role
in morphological changes and vascular hyporeactivity.
There were significant differences between the sham and
CLP groups in terms of smooth muscle contraction, but
HMGB1 expression in smooth muscle cells was compa-
rable among the sham, CLP ? 4 mgAb, and CLP ?
0.4 mgAb groups shortly after the preparation. Therefore,
HMGB1 expression did not exactly correlate with vascular
contraction. This result indicates that HMGB1 expression
is not the sole factor inducing hyporeactivity of the aorta
during sepsis. Other factors including activated macro-
phages [6] attached to the endothelium and overproduction
of nitric oxide [13–15] and prostaglandins [16, 18] may
account for this hyporeactivity.
There are several drawbacks in our experiment. We did
not measure the serum levels of HMGB1 or other cyto-
kines. We do not know how anti-HMGB1 antibody influ-
enced those cytokine levels. However, our results agreed
very well with those of previous studies showing that CLP
surgery induced HMGB1 expression at tissue level and that
anti-HMGB1 antibody effectively reversed this alteration
[19, 30]. Rat aortae were harvested 12 h after the surgery
and were immersed in PSS without HMGB1 or cytokines,
which should have influenced the results. We suppose,
however, that the alteration would have been more accel-
erated and intense than the one we observed when the rings
were in situ. We postulated 40 mM KCl-induced tension as
a reference contraction shortly after excision of the aortae
and did not measure the absolute force of the aortic rings.
Thus, KCl-induced contraction could have been attenuated
even at 12 h after surgery in the CLP groups. Yet, if this
were true, the differences in muscle tension between the
sham group and the CLP groups and among the CLP
groups should have been more obvious.
In conclusion, CLP surgery induced HMGB1 expression
in the rat aorta, which was accompanied by morphological
and functional derangement. Anti-HMGB1 antibody could
partly reverse these alterations after CLP. Expression of
HMGB1 in the endothelium and smooth muscle cells could
be another cause of hemodynamic perturbation even from
an early phase of severe sepsis.
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